Literature DB >> 12614152

A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium.

Heidi R Bokesch1, Barry R O'Keefe, Tawnya C McKee, Lewis K Pannell, Gregory M L Patterson, Roberta S Gardella, Raymond C Sowder, Jim Turpin, Karen Watson, Robert W Buckheit, Michael R Boyd.   

Abstract

A new anti-HIV protein, scytovirin, was isolated from aqueous extracts of the cultured cyanobacterium Scytonema varium. The protein displayed potent anticytopathic activity against laboratory strains and primary isolates of HIV-1 with EC50 values ranging from 0.3 to 22 nM. Scytovirin binds to viral coat proteins gp120, gp160, and gp41 but not to cellular receptor CD4 or other tested proteins. This unique protein consists of a single 95-amino acid chain with significant internal sequence duplication and 10 cysteines forming five intrachain disulfide bonds.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614152     DOI: 10.1021/bi0205698

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  59 in total

1.  Novel fold and carbohydrate specificity of the potent anti-HIV cyanobacterial lectin from Oscillatoria agardhii.

Authors:  Leonardus M I Koharudin; William Furey; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

Review 2.  HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.

Authors:  Priyamvada Acharya; Sabrina Lusvarghi; Carole A Bewley; Peter D Kwong
Journal:  Expert Opin Ther Targets       Date:  2015-02-27       Impact factor: 6.902

3.  Atomic-resolution crystal structure of the antiviral lectin scytovirin.

Authors:  Tinoush Moulaei; Istvan Botos; Natasza E Ziółkowska; Heidi R Bokesch; Lauren R Krumpe; Tawnya C McKee; Barry R O'Keefe; Zbigniew Dauter; Alexander Wlodawer
Journal:  Protein Sci       Date:  2007-10-26       Impact factor: 6.725

4.  Structural basis of the anti-HIV activity of the cyanobacterial Oscillatoria Agardhii agglutinin.

Authors:  Leonardus M I Koharudin; Angela M Gronenborn
Journal:  Structure       Date:  2011-08-10       Impact factor: 5.006

5.  The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus.

Authors:  Aura R Garrison; Barbara G Giomarelli; Calli M Lear-Rooney; Carrie J Saucedo; Srikanth Yellayi; Lauren R H Krumpe; Maura Rose; Jason Paragas; Mike Bray; Gene G Olinger; James B McMahon; John Huggins; Barry R O'Keefe
Journal:  Antiviral Res       Date:  2014-10-05       Impact factor: 5.970

6.  The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.

Authors:  Kabamba B Alexandre; Elin S Gray; Hazel Mufhandu; James B McMahon; Ereck Chakauya; Barry R O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  Virology       Date:  2011-12-29       Impact factor: 3.616

7.  Differential inhibitory effects of cyanovirin-N, griffithsin, and scytovirin on entry mediated by envelopes of gammaretroviruses and deltaretroviruses.

Authors:  Stig M R Jensen; Francis W Ruscetti; Alan Rein; Daniel C Bertolette; Carrie J Saucedo; Barry R O'Keefe; Kathryn S Jones
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

Review 8.  Carbohydrate recognition by boronolectins, small molecules, and lectins.

Authors:  Shan Jin; Yunfeng Cheng; Suazette Reid; Minyong Li; Binghe Wang
Journal:  Med Res Rev       Date:  2010-03       Impact factor: 12.944

Review 9.  Cyanobactins-ribosomal cyclic peptides produced by cyanobacteria.

Authors:  Kaarina Sivonen; Niina Leikoski; David P Fewer; Jouni Jokela
Journal:  Appl Microbiol Biotechnol       Date:  2010-02-27       Impact factor: 4.813

10.  HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin.

Authors:  Lakshmi Krishnamoorthy; Julian W Bess; Alex B Preston; Kunio Nagashima; Lara K Mahal
Journal:  Nat Chem Biol       Date:  2009-02-22       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.